GSK
GlaxoSmithKline PLC
50.50$
+0.3%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +31.5% | +10.5% | -4.6% | +3.0% | +81.8% | +4.1% | -2.6% | -43.9% | +25.1% | -20.9% | +2.6% | |
| – | +13.0% | +0.7% | -4.8% | +6.4% | +52.5% | +7.2% | -8.6% | -17.9% | +14.4% | -28.5% | +2.8% | |
| – | +34.4% | -16.0% | -21.7% | +1.1% | +61.0% | +37.9% | -32.7% | -35.7% | +0.5% | -1.3% | -8.2% | |
| – | +34.0% | -15.6% | -21.6% | +1.2% | +60.2% | +37.3% | -32.6% | +34.2% | -16.1% | -43.8% | -8.5% | |
| – | -13.5% | +52.5% | +0.6% | +6.3% | +49.8% | +4.9% | +9.5% | -42.8% | +51.8% | -36.4% | +29.1% | |
| – | +11.5% | +8.2% | +8.9% | -1.5% | +43.9% | +4.0% | -4.4% | -34.3% | +36.2% | -19.1% | +4.3% | |
| – | -31.4% | +11.8% | +0.5% | +1.8% | +2.3% | -2.7% | -3.0% | -9.9% | +3.5% | +1.2% | -0.2% | |
| – | +38.6% | +15.6% | -3.9% | +1.0% | +141.7% | +3.5% | -1.3% | -50.7% | +23.2% | -19.6% | +0.3% | |
| – | +100.4% | +12.6% | -6.5% | -2.0% | +138.4% | -0.6% | -0.1% | -64.9% | +31.5% | -17.6% | +7.8% | |
| – | +24.8% | +21.4% | -2.3% | +2.8% | +49.4% | +0.3% | -4.0% | -36.0% | +17.7% | -21.3% | -2.9% | |
| – | +0.9% | +41.6% | +39.8% | -15.3% | +41.7% | -5.0% | +5.9% | -28.9% | +17.7% | -19.2% | -1.6% | |
| – | -55.6% | +215.7% | -31.6% | +105.1% | +58.2% | -44.4% | -4.2% | -19.0% | -9.3% | -34.5% | +28.0% | |
| – | +15.5% | +30.2% | +75.3% | -82.6% | +50.6% | +8.5% | +3.1% | -37.1% | +22.6% | -26.9% | +343.5% | |
| – | -38.1% | -4.3% | -2.7% | +42.2% | +11.6% | +3.7% | -12.2% | -17.2% | -16.9% | -3.2% | +2.3% | |
| – | +79.9% | -44.1% | -29.7% | +8.4% | +299.6% | +32.0% | +2.3% | -48.0% | +60.5% | -19.7% | +19.6% | |
| – | – | – | – | – | – | +39.2% | +12.8% | -67.1% | +111.5% | -15.5% | +30.7% | |
| – | +0.5% | +0.4% | +0.7% | +0.6% | +0.9% | +0.4% | -19.6% | +26.0% | +0.7% | +0.8% | -0.6% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.